| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/24/2008 | WO2008010472A1 Total enteral nutrition composition |
| 01/24/2008 | WO2008009894A2 Use of imino sugars in immunotherapy |
| 01/24/2008 | WO2008009639A2 New indications for direct thrombin inhibitors |
| 01/24/2008 | WO2008009638A2 New indications for direct thrombin inhibitors in the cardiovascular field |
| 01/24/2008 | WO2008009635A2 Factor viia analogues with increased activity for treating thrombocytopenia |
| 01/24/2008 | WO2008009634A2 Factor viia analogues with increased activity for treating thrombocytopenia |
| 01/24/2008 | WO2007133653A3 Methods for treating blood disorders |
| 01/24/2008 | WO2007088343A3 Granular material comprising water- insoluble inorganic phosphate binders |
| 01/24/2008 | US20080021109 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/24/2008 | US20080021065 Novel benzamidine compound |
| 01/24/2008 | US20080021044 N-[2-[[(diaminomethylene)amino]oxy]ethyl]-3-[(2,2-difluoro-2-phenylethyl)amino]-6-methyl-2-oxo-1(2h)-pyrazineacetamide |
| 01/24/2008 | US20080021029 Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors |
| 01/24/2008 | US20080021013 JAK inhibitors for treatment of myeloproliferative disorders |
| 01/24/2008 | US20080020994 G proteins in tumor growth and angiogenesis |
| 01/24/2008 | US20080020990 Oligo Double-Stranded Rna Inhibiting the Expression of Bcl-2 and Pharmaceutical Composition Containing the Same |
| 01/24/2008 | US20080020970 For promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation |
| 01/24/2008 | US20080020969 36 Human Secreted Proteins |
| 01/24/2008 | US20080020965 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080020070 Citrus Fruit Skin Extract for Angiogenesis Promotion |
| 01/24/2008 | US20080020063 Anti-angiogenic compositions and methods of use |
| 01/24/2008 | US20080020026 Hemostatic compositions and methods for controlling bleeding |
| 01/24/2008 | US20080019985 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080019915 including cystic fibrosis transmembrane conductance regulator ("CFTR"); N[6-(2-hydroxymethylphenyl-1yl)-5-methylpyrimidine][(4-methoxophenyl-1-yl)cyclopopyl]-amide; genetic disorders; respiratory system disorders, cystic fibrosis, hereditary emphysema and hemochromatosis, coagulation-fibrinolysis |
| 01/24/2008 | CA2829865A1 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders |
| 01/24/2008 | CA2657269A1 New indications for direct thrombin inhibitors |
| 01/24/2008 | CA2657266A1 New indications for direct thrombin inhibitors in the cardiovascular field |
| 01/23/2008 | EP1880994A1 Crystal of indole derivative having piperidine ring and process for production thereof |
| 01/23/2008 | EP1879909A1 Stabilizer molecule-enriched albumin solution |
| 01/23/2008 | EP1879864A1 Fluorinated pyridine n-oxide thrombin modulators and process for n-oxidation of nitrogen containing heteroaryls |
| 01/23/2008 | EP1879610A1 Use of an immunoglobulin domain-containing cell surface recognition molecule for treating diseases |
| 01/23/2008 | EP1879609A2 Use of histones for therapeutic purposes |
| 01/23/2008 | EP1879606A1 Compositions and methods for promoting hemostasis and other physiological activities |
| 01/23/2008 | EP1879585A1 Use of pyrimidylamimobenzamide derivatives for the treatment of systematic mastocytosis |
| 01/23/2008 | EP1879584A1 Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome |
| 01/23/2008 | EP1409479B1 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazines and -piperidines as factor xa antagonists |
| 01/23/2008 | EP1272178B1 Bilirubin or biliverdin degradation fragments |
| 01/23/2008 | EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/23/2008 | EP0986376B1 USE OF A FACTOR Xa INHIBITing oligosaccharide WITH A PLATELET ANTIAGGREGATING AGENT FOR TREATING ARTERIAL THROMBOSIS |
| 01/23/2008 | CN101111491A Processes and compounds for the preparation of substituted naphthylindole derivatives |
| 01/23/2008 | CN101111470A Crystalline acat (acyl-coa:cholesterol o-acyltransferase) inhibitor |
| 01/23/2008 | CN101111237A Methods for improving drug disposition |
| 01/23/2008 | CN101111236A Prevention and treatment of thromboembolic disorders |
| 01/23/2008 | CN101109012A Representation of vampire plasmin activator alpha 2 in yeast and manufacturing method thereof |
| 01/23/2008 | CN101108234A Traditional Chinese medicine composition treating megakaryocytic leukemia |
| 01/23/2008 | CN101108218A Traditional Chinese medicine composition for treating granular leukocyte leukocythemia |
| 01/23/2008 | CN101108217A Chinese medicinal herb for treating hemopathy |
| 01/23/2008 | CN101108216A Traditional Chinese medicine composition for treating rubricyte leukocythemia |
| 01/23/2008 | CN101108189A Application of estrogen for preparing medicament assisting or separately treating and preventing uterine inertia type post partum bleeding disease of puerpera |
| 01/23/2008 | CN101108188A Novel long circulation alprostadil liposome drug feeding system for injection and method of preparing the same |
| 01/23/2008 | CN101107995A Traditional Chinese medicine health care beverage bag |
| 01/23/2008 | CN100363053C Intracellular isoform of the interleukin-1 receptor antagonist |
| 01/23/2008 | CN100363034C Chinese medicinal composition for treating ascites due to cirrhosis |
| 01/23/2008 | CN100363007C Slow release preparation containing larmotriazine |
| 01/22/2008 | US7320999 Immunosuppressants, organ transplantation, autoimmune diseases, rheumatic diseases |
| 01/22/2008 | US7320982 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1 |
| 01/22/2008 | US7320880 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and DNA coding for the same |
| 01/22/2008 | CA2312431C New compounds |
| 01/22/2008 | CA2303807C Bioresorbable compositions for implantable prostheses |
| 01/17/2008 | WO2008007755A1 Cell death inducer |
| 01/17/2008 | WO2008006979A2 Process for preparing diaminophenothiazinium compounds |
| 01/17/2008 | WO2008006257A1 2,4,5-trisubstituted thiazole compounds,preparation methods, pharmaceutical compositions and medical uses thereof |
| 01/17/2008 | WO2008006189A1 Mimotope receptors and inhibitors for platelet- platelet and platelet-endothelium interactions |
| 01/17/2008 | WO2008006168A1 Treatment of excessive neovascularization |
| 01/17/2008 | WO2007136641A3 Methods of treating acute blood loss anemia with a cross-linked hemoglobin blood substitute |
| 01/17/2008 | WO2004106938A3 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7) |
| 01/17/2008 | US20080015215 Diamine derivatives |
| 01/17/2008 | US20080015209 Compounds for the treatment of metabolic disorders |
| 01/17/2008 | US20080015199 Triazolone derivatives |
| 01/17/2008 | US20080015188 Stable pharmaceutical compositions of 2-aza-bicyclo(3.3.0)-octane-3-carboxylic acid derivatives |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015178 Benzimidazoles, process for their preparation and use thereof as medicament |
| 01/17/2008 | US20080015174 Metabolic Disease Treatments |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080015146 e.g. 3-Amino-1-[(S)-2-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-4-(2,4,5-trifluorophenyl)-butan-1-one; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes |
| 01/17/2008 | US20080014288 Zinc-containing treatments for hyperphosphatemia |
| 01/17/2008 | US20080014249 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 01/17/2008 | US20080014246 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/17/2008 | US20080014239 Multiple heparin molecules that are end-to-side and/or end-to-end connected glycosaminoglycan units attached to a globular core molecule, such as serum albumin, by a spacer such as N-succinylimidyl 3-(2-pyridyldithio)propionate; inhibition of collagen-induced platelet aggregation |
| 01/17/2008 | US20080014228 Solid form |
| 01/17/2008 | DE102006032824A1 Substituierte Indazole Substituted indazoles |
| 01/17/2008 | CA2657535A1 Process for preparing diaminophenothiazinium compounds |
| 01/17/2008 | CA2657310A1 Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions |
| 01/17/2008 | CA2657308A1 Treatment of excessive neovascularization |
| 01/16/2008 | EP1878748A2 Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 costimulatory antigens |
| 01/16/2008 | EP1878727A1 2-aminoquinazoline derivatives |
| 01/16/2008 | EP1878441A2 Complement pathway inhibitors binding to C5 and C5a without preventing the formation of C5b |
| 01/16/2008 | EP1878430A1 Peritoneal dialysis fluid |
| 01/16/2008 | EP1877404A2 Novel cyclic amines |
| 01/16/2008 | EP1877395A2 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]propionic acid ethyl ester |
| 01/16/2008 | EP1877037A2 A closed container comprising an activated factor vii polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit |
| 01/16/2008 | EP1429754B1 Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 01/16/2008 | EP1278532B1 Plant extract of the olea europaea species as no-synthase inhibitor and uses |
| 01/16/2008 | EP1261694B1 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 01/16/2008 | EP1204626B1 Ether compounds, compositions, and uses thereof |
| 01/16/2008 | EP1200118B1 A pharmaceutical formulation comprising megalatran and its prodrug |
| 01/16/2008 | EP1198255B1 Identification of compounds that modify transcriptional responses to hypoxia |
| 01/16/2008 | EP1077998B1 Labelled glutamine and lysine analogues |
| 01/16/2008 | CN101104847A Vipera berus snake poison blood coagulation X factor activating enzyme and its extracting method and application |
| 01/16/2008 | CN101104650A Ceanothus polysaccharide sulfate and its preparing process and application |
| 01/16/2008 | CN101103985A Folic acid dropping pill and its preparation method |